ZNF692 and cancer: The findings illustrated in Figure 2A demonstrated a statistically significant association between the expression of ZNF692 and unfavorable overall survival (OS) in several cancer types, including ACC (p < 0.001), COAD (p = 0.0067), KIRC (p < 0.0001), LAML (p = 0.0375), and LIHC (p = 0.0105).